,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.0,No adverse event,16578156
0,6,22.0,Neoplasm progression,16578158
1,6,22.0,Panic reaction,16578158
0,2,22.1,Weight decreased,16578169
1,2,22.1,Tooth fracture,16578169
2,6,22.1,Diarrhoea,16578169
0,6,22.0,White blood cell count decreased,16578171
1,6,22.0,Platelet count decreased,16578171
2,6,22.0,Red blood cell count decreased,16578171
0,3,22.0,Asthenia,16578200
1,3,22.0,Abdominal distension,16578200
2,3,22.0,General physical health deterioration,16578200
0,3,22.0,Pneumonia,16578228
0,1,22.0,Gastrooesophageal reflux disease,16578249
0,3,22.1,Nasopharyngitis,16578267
1,6,22.1,Dehydration,16578267
2,6,22.1,Visual impairment,16578267
3,6,22.1,Blood pressure increased,16578267
4,6,22.1,Asthenia,16578267
5,6,22.1,Blood count abnormal,16578267
0,6,22.0,Nausea,16578310
1,6,22.0,Vision blurred,16578310
2,2,22.0,Headache,16578310
3,6,22.0,Decreased appetite,16578310
4,6,22.0,Diarrhoea,16578310
5,6,22.0,Arthralgia,16578310
6,1,22.0,Hypertension,16578310
7,6,22.0,Blood urine present,16578310
8,6,22.0,Balance disorder,16578310
9,2,22.0,Pyrexia,16578310
10,6,22.0,Dizziness,16578310
0,3,22.0,Stevens-Johnson syndrome,16578361
0,2,22.0,Blood pressure decreased,16578376
1,2,22.0,Epistaxis,16578376
2,2,22.0,Coronary artery disease,16578376
3,2,22.0,Mouth haemorrhage,16578376
0,2,22.0,Neutrophil count decreased,16578377
1,2,22.0,Platelet count decreased,16578377
2,2,22.0,White blood cell count decreased,16578377
0,1,22.1,Hepatocellular injury,16578567
0,6,22.0,Hepatitis B reactivation,16578737
0,6,22.0,Inappropriate schedule of product administration,16578744
1,5,22.0,Malignant neoplasm progression,16578744
2,6,22.0,Packed red blood cell transfusion,16578744
3,6,22.0,Product use in unapproved indication,16578744
0,3,22.0,Onychoclasis,16578746
1,3,22.0,Rash,16578746
2,3,22.0,Food intolerance,16578746
3,3,22.0,Malaise,16578746
4,6,22.0,Impaired healing,16578746
5,3,22.0,Localised infection,16578746
6,3,22.0,Wound,16578746
0,2,22.1,Arterial disorder,16578810
1,2,22.1,Cerebral infarction,16578810
0,1,22.0,Toxicity to various agents,16578837
1,1,22.0,Neurotoxicity,16578837
2,1,22.0,Mucosal toxicity,16578837
0,6,22.0,Fatigue,16578886
1,6,22.0,Back pain,16578886
2,6,22.0,Malignant neoplasm progression,16578886
3,6,22.0,Interstitial lung disease,16578886
4,6,22.0,Hypothyroidism,16578886
5,6,22.0,Prostatic specific antigen increased,16578886
0,1,22.0,Pulmonary embolism,16578974
1,1,22.0,Neutropenia,16578974
2,1,22.0,Anaemia,16578974
3,2,22.0,Neuropathy peripheral,16578974
4,1,22.0,General physical health deterioration,16578974
0,2,22.0,Neuropathy peripheral,16578983
1,2,22.0,Neutropenia,16578983
2,2,22.0,Hot flush,16578983
3,2,22.0,Alopecia,16578983
4,2,22.0,Dry skin,16578983
0,2,22.0,Dizziness,16579046
0,2,22.0,Hypomagnesaemia,16579065
1,2,22.0,Hypocalcaemia,16579065
2,3,22.0,Diarrhoea,16579065
3,2,22.0,Hypokalaemia,16579065
0,6,22.0,Hepatitis B reactivation,16579068
0,5,22.0,Metastases to central nervous system,16579076
0,6,22.0,Hepatic cancer,16579083
0,1,22.0,Hepatitis,16579085
1,3,22.0,Asthenia,16579085
2,6,22.0,Product storage error,16579085
3,3,22.0,Lung carcinoma cell type unspecified recurrent,16579085
0,6,22.0,Crowned dens syndrome,16579092
1,1,22.0,Pyrexia,16579092
2,1,22.0,Neck pain,16579092
0,3,22.0,Malignant neoplasm progression,16579095
0,6,22.0,Lacrimal disorder,16579104
1,6,22.0,Lacrimation increased,16579104
2,6,22.0,Dacryostenosis acquired,16579104
0,6,22.0,Lacrimation increased,16579105
1,6,22.0,Dacryostenosis acquired,16579105
0,6,22.0,Lacrimation increased,16579106
1,6,22.0,Dacryostenosis acquired,16579106
0,3,22.0,Lacrimation increased,16579107
1,3,22.0,Dacryostenosis acquired,16579107
0,6,22.0,Dacryostenosis acquired,16579112
1,6,22.0,Lacrimation increased,16579112
0,6,22.0,Lacrimation increased,16579114
1,6,22.0,Dacryostenosis acquired,16579114
0,6,22.0,Lacrimal disorder,16579115
1,6,22.0,Lacrimation increased,16579115
2,6,22.0,Dacryostenosis acquired,16579115
0,6,22.0,Lacrimation increased,16579116
1,6,22.0,Dacryostenosis acquired,16579116
2,6,22.0,Lacrimal disorder,16579116
0,6,22.0,Lacrimation increased,16579117
1,6,22.0,Dacryostenosis acquired,16579117
2,6,22.0,Lacrimal disorder,16579117
0,1,22.0,Lacrimation increased,16579118
1,1,22.0,Dacryostenosis acquired,16579118
0,6,22.1,Pneumonia,16579121
1,6,22.1,Embolism,16579121
0,6,22.0,Malignant neoplasm progression,16579195
0,1,22.1,Hepatic function abnormal,16579308
0,6,22.0,Skin disorder,16579446
1,6,22.0,Malignant neoplasm progression,16579446
2,2,22.0,Hypersensitivity,16579446
3,6,22.0,Dyspnoea,16579446
0,5,22.0,Death,16579476
0,1,22.0,Acute kidney injury,16579477
1,,22.0,Nausea,16579477
0,5,22.0,Disease progression,16579493
0,,22.0,Off label use,16579502
1,6,22.0,Hospitalisation,16579502
2,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16579502
0,5,22.0,Sepsis,16579519
1,5,22.0,Prerenal failure,16579519
0,2,22.0,Vascular skin disorder,16579536
1,2,22.0,Dermatitis bullous,16579536
0,3,22.0,Tumour pseudoprogression,16579559
1,3,22.0,Malignant neoplasm progression,16579559
0,5,22.0,Death,16579656
0,3,22.0,Hepatic infection,16579681
0,6,22.1,Radiation pneumonitis,16580032
0,2,22.0,Renal failure,16580055
1,2,22.0,Altered state of consciousness,16580055
2,2,22.0,Hepatic failure,16580055
0,6,22.0,Neoplasm progression,16580059
0,1,22.0,Gravitational oedema,16580144
1,1,22.0,Pyrexia,16580144
2,1,22.0,Neutropenia,16580144
0,2,22.0,Neutropenia,16580147
1,3,22.0,Rash,16580147
2,6,22.0,Inappropriate schedule of product administration,16580147
3,2,22.0,Leukopenia,16580147
0,1,22.0,Malignant neoplasm of renal pelvis,16580148
1,1,22.0,Asthma,16580148
0,3,22.0,Thrombocytopenia,16580154
1,3,22.0,Dysphagia,16580154
2,2,22.0,Acute kidney injury,16580154
3,3,22.0,Mucosal inflammation,16580154
4,1,22.0,Hypokalaemia,16580154
5,1,22.0,Agranulocytosis,16580154
0,6,22.1,Neuropathy peripheral,16580156
1,6,22.1,Intercostal neuralgia,16580156
2,6,22.1,Musculoskeletal chest pain,16580156
3,6,22.1,Tenderness,16580156
4,6,22.1,Abdominal pain,16580156
5,6,22.1,Decreased appetite,16580156
6,6,22.1,Back pain,16580156
7,6,22.1,Weight decreased,16580156
8,6,22.1,Pneumonia,16580156
9,6,22.1,Metastasis,16580156
10,6,22.1,Respiratory tract congestion,16580156
11,6,22.1,Hypercalcaemia,16580156
12,6,22.1,Pain,16580156
13,6,22.1,Facial pain,16580156
14,6,22.1,Fatigue,16580156
15,6,22.1,Asthenia,16580156
16,6,22.1,Atrioventricular block first degree,16580156
17,6,22.1,Nausea,16580156
18,6,22.1,Oxygen saturation decreased,16580156
19,6,22.1,Metastases to lung,16580156
20,6,22.1,Chest discomfort,16580156
0,3,22.1,Pruritus,16580187
1,3,22.1,Exfoliative rash,16580187
2,3,22.1,Bone pain,16580187
3,6,22.1,Arthralgia,16580187
4,6,22.1,Fatigue,16580187
5,6,22.1,Photosensitivity reaction,16580187
6,3,22.1,Pruritus,16580187
7,3,22.1,Abdominal pain,16580187
8,3,22.1,Skin exfoliation,16580187
0,1,22.1,Diarrhoea,16580211
1,1,22.1,Pyrexia,16580211
2,1,22.1,Febrile neutropenia,16580211
3,1,22.1,Headache,16580211
4,2,22.1,Cough,16580211
5,1,22.1,Thrombocytopenia,16580211
6,1,22.1,Vomiting,16580211
7,1,22.1,Headache,16580211
8,1,22.1,Pyrexia,16580211
9,2,22.1,Rhinorrhoea,16580211
10,1,22.1,Nausea,16580211
11,6,22.1,Asthenia,16580211
0,1,22.0,Rash,16580214
0,6,22.0,Blood bilirubin increased,16580262
1,3,22.0,Alanine aminotransferase increased,16580262
2,6,22.0,Blood lactate dehydrogenase increased,16580262
3,3,22.0,Aspartate aminotransferase increased,16580262
4,3,22.0,Gamma-glutamyltransferase increased,16580262
5,6,22.0,Blood alkaline phosphatase increased,16580262
6,6,22.0,Metastases to liver,16580262
0,1,22.0,Throat irritation,16580269
1,1,22.0,Feeling cold,16580269
2,1,22.0,Rash,16580269
0,1,22.0,Throat tightness,16580293
1,1,22.0,Nausea,16580293
2,1,22.0,Rash,16580293
3,1,22.0,Hypotension,16580293
0,1,22.0,Pyrexia,16580322
0,2,22.0,Calcium deficiency,16580406
1,3,22.0,Chapped lips,16580406
2,2,22.0,Haemoglobin decreased,16580406
3,3,22.0,Blood iron decreased,16580406
4,3,22.0,Product use in unapproved indication,16580406
5,3,22.0,Immunodeficiency,16580406
6,2,22.0,Toothache,16580406
0,6,22.0,Bone marrow failure,16580446
1,6,22.0,Fatigue,16580446
2,6,22.0,Neoplasm progression,16580446
3,6,22.0,Dyspnoea,16580446
0,2,22.0,Cholestasis,16580498
1,2,22.0,Tubulointerstitial nephritis,16580498
0,6,22.0,Presyncope,16580525
1,6,22.0,Vomiting,16580525
2,6,22.0,Drug interaction,16580525
3,6,22.0,Muscle spasms,16580525
4,6,22.0,Asthenia,16580525
0,6,22.0,Neoplasm progression,16580540
0,1,22.0,Acute kidney injury,16580598
0,5,22.0,Acute respiratory failure,16580668
0,6,22.0,Dyspnoea at rest,16580675
1,6,22.0,Pulmonary embolism,16580675
2,6,22.0,Dyspnoea exertional,16580675
3,6,22.0,Pyrexia,16580675
4,5,22.0,Death,16580675
0,1,22.0,Pyrexia,16580676
1,1,22.0,Gravitational oedema,16580676
2,1,22.0,Neutropenia,16580676
0,1,22.0,Skin toxicity,16580707
1,1,22.0,Thrombocytopenia,16580707
2,1,22.0,Neutropenia,16580707
0,6,22.0,Electrocardiogram ST segment elevation,16580836
1,6,22.0,Myocardial infarction,16580836
2,6,22.0,Kounis syndrome,16580836
0,6,22.1,Weight decreased,16580876
0,6,22.0,Alopecia,16580883
1,6,22.0,Decreased appetite,16580883
2,6,22.0,Neoplasm progression,16580883
0,3,22.1,Hyperhidrosis,16580886
1,3,22.1,Condition aggravated,16580886
2,1,22.1,Nasopharyngitis,16580886
3,3,22.1,Insomnia,16580886
4,3,22.1,Alopecia,16580886
0,3,22.1,Stomatitis,16580904
1,3,22.1,Fatigue,16580904
2,3,22.1,Rash,16580904
3,6,22.1,Hot flush,16580904
0,5,22.0,Death,16580923
1,6,22.0,Drug ineffective,16580923
2,6,22.0,Multiple fractures,16580923
0,2,22.0,Clostridium difficile infection,16580925
1,1,22.0,Dysphagia,16580925
2,2,22.0,Fatigue,16580925
3,1,22.0,Diarrhoea,16580925
4,6,22.0,Decreased appetite,16580925
0,2,22.0,Tooth resorption,16581003
0,2,22.0,Oedema peripheral,16581010
1,6,22.0,Off label use,16581010
2,6,22.0,Prescribed underdose,16581010
3,2,22.0,Pericardial effusion,16581010
4,2,22.0,Pleural effusion,16581010
0,3,22.0,Myocardial ischaemia,16581033
0,6,22.0,Renal failure,16581408
0,4,22.0,Peripheral ischaemia,16581428
0,6,22.0,Neoplasm progression,16581647
0,6,22.0,Cardiotoxicity,16581701
1,6,22.0,Urinary tract infection,16581701
2,6,22.0,Neuropathy peripheral,16581701
3,6,22.0,Mucosal inflammation,16581701
4,6,22.0,Febrile neutropenia,16581701
5,6,22.0,Left ventricular dysfunction,16581701
0,1,22.0,Insomnia,16581722
1,1,22.0,Delirium,16581722
2,1,22.0,Affective disorder,16581722
3,3,22.0,Anaemia,16581722
4,3,22.0,Blood alkaline phosphatase increased,16581722
5,1,22.0,Logorrhoea,16581722
0,1,22.0,Blood sodium decreased,16581727
1,6,22.0,Rash,16581727
0,3,22.0,Vulvovaginal burning sensation,16581783
0,2,22.1,Vertigo,16581870
1,2,22.1,Rash,16581870
2,2,22.1,Nausea,16581870
3,6,22.1,Overdose,16581870
4,3,22.1,Headache,16581870
5,3,22.1,Somnolence,16581870
0,5,22.0,Sudden death,16581871
1,6,22.0,Sinus tachycardia,16581871
2,6,22.0,Pain,16581871
0,6,22.0,Chest pain,16581884
1,6,22.0,Arthralgia,16581884
2,6,22.0,Pain in extremity,16581884
0,6,22.1,Hypoaesthesia,16581912
1,1,22.1,Cardiomyopathy,16581912
2,6,22.1,Epistaxis,16581912
3,1,22.1,Cardiac failure,16581912
4,6,22.1,Cough,16581912
5,6,22.1,Nail disorder,16581912
6,1,22.1,Cystitis,16581912
0,6,22.0,Myocarditis,16581929
0,2,22.0,Respiratory distress,16581969
1,2,22.0,Transaminases increased,16581969
2,2,22.0,Shock,16581969
3,1,22.0,Sepsis,16581969
4,2,22.0,Acute kidney injury,16581969
5,2,22.0,Pulmonary embolism,16581969
6,2,22.0,Pyrexia,16581969
7,2,22.0,Delirium,16581969
0,6,22.0,White blood cell count decreased,16582046
1,6,22.0,Red blood cell count decreased,16582046
2,6,22.0,Basophil count increased,16582046
3,6,22.0,Femur fracture,16582046
4,6,22.0,Mean cell haemoglobin increased,16582046
5,6,22.0,Gait disturbance,16582046
6,6,22.0,Neutrophil count increased,16582046
7,6,22.0,Mean cell volume increased,16582046
8,6,22.0,Haematocrit decreased,16582046
0,3,22.0,Cognitive disorder,16582090
1,3,22.0,Language disorder,16582090
2,3,22.0,Memory impairment,16582090
0,6,22.0,Intentional product use issue,16582108
1,6,22.0,Drug ineffective,16582108
2,6,22.0,Off label use,16582108
3,6,22.0,Oestrogen receptor assay positive,16582108
0,5,22.0,Interstitial lung disease,16582116
1,5,22.0,Pneumothorax,16582116
0,,22.1,Pyrexia,16582130
1,,22.1,Blood pressure decreased,16582130
2,,22.1,Off label use,16582130
3,,22.1,Heart rate increased,16582130
4,,22.1,Rash,16582130
5,,22.1,Hospitalisation,16582130
0,5,22.0,Cardiac arrest,16582133
0,4,22.0,Cardiac failure,16582136
1,4,22.0,Atrial fibrillation,16582136
0,6,22.0,Insomnia,16582190
1,5,22.0,Breast cancer metastatic,16582190
2,6,22.0,Thrombocytopenia,16582190
3,6,22.0,Vomiting,16582190
4,1,22.0,Neutropenia,16582190
5,6,22.0,Dehydration,16582190
6,1,22.0,Leukopenia,16582190
7,6,22.0,Hypokalaemia,16582190
8,6,22.0,Drug eruption,16582190
9,6,22.0,Nausea,16582190
10,6,22.0,Pancytopenia,16582190
11,6,22.0,Hyponatraemia,16582190
0,6,22.0,Interstitial lung disease,16582238
1,6,22.0,Pneumonitis,16582238
2,6,22.0,Hepatic steatosis,16582238
3,2,22.0,Sensorimotor disorder,16582238
4,6,22.0,Liver scan abnormal,16582238
5,6,22.0,Hepatic cyst,16582238
0,6,22.0,Delirium,16582329
1,5,22.0,Myocardial ischaemia,16582329
2,5,22.0,Acute kidney injury,16582329
3,6,22.0,Effusion,16582329
4,5,22.0,Pneumonia,16582329
5,5,22.0,Chronic obstructive pulmonary disease,16582329
6,5,22.0,Cardiac failure congestive,16582329
0,3,22.0,Disease progression,16582434
1,6,22.0,Drug ineffective,16582434
2,2,22.0,Chest pain,16582434
0,6,22.0,Fatigue,16582453
1,3,22.0,Hypothyroidism,16582453
2,3,22.0,Drug interaction,16582453
3,3,22.0,Myalgia,16582453
4,3,22.0,Diarrhoea,16582453
5,3,22.0,Decreased appetite,16582453
6,3,22.0,Weight decreased,16582453
0,1,22.0,Hepatocellular injury,16582517
0,1,22.0,Asphyxia,16582541
1,1,22.0,Muscle spasticity,16582541
2,1,22.0,Erythema,16582541
0,6,22.0,Condition aggravated,16582543
1,6,22.0,Fluid retention,16582543
2,6,22.0,White blood cell count decreased,16582543
3,6,22.0,Dyspnoea,16582543
4,6,22.0,Neuropathy peripheral,16582543
5,6,22.0,Weight increased,16582543
0,1,22.0,Urticaria,16582549
1,1,22.0,Hypersensitivity,16582549
2,1,22.0,Tachycardia,16582549
3,1,22.0,Erythema,16582549
0,2,22.0,Acute febrile neutrophilic dermatosis,16582553
0,6,22.0,Off label use,16582604
1,6,22.0,Product use in unapproved indication,16582604
2,5,22.0,Death,16582604
3,6,22.0,No adverse event,16582604
0,1,22.0,Intervertebral disc protrusion,16582617
0,3,22.0,Parkinson^s disease,16582624
1,3,22.0,Dysphagia,16582624
2,6,22.0,Intentional dose omission,16582624
3,6,22.0,Wrong technique in product usage process,16582624
0,1,22.0,Back pain,16582690
1,1,22.0,Hypersensitivity,16582690
0,6,22.0,Anaemia,16582696
1,6,22.0,Facial paralysis,16582696
2,6,22.0,Visual impairment,16582696
3,6,22.0,Eye disorder,16582696
4,3,22.0,Yellow skin,16582696
5,6,22.0,Optic nerve disorder,16582696
0,6,22.0,Hepatic function abnormal,16582697
1,6,22.0,Renal impairment,16582697
0,6,22.0,Disease progression,16582763
1,6,22.0,Drug intolerance,16582763
2,6,22.0,Drug ineffective,16582763
3,6,22.0,Diarrhoea,16582763
0,6,22.1,Abdominal pain,16582766
1,2,22.1,Abdominal discomfort,16582766
2,6,22.1,Fatigue,16582766
3,6,22.1,Malaise,16582766
0,5,22.0,Lower respiratory tract infection,16582773
1,5,22.0,Neoplasm progression,16582773
0,5,22.0,Malignant neoplasm progression,16582780
0,6,22.1,Incorrect dose administered,16582849
1,6,22.1,Product contamination physical,16582849
0,1,22.1,Lower respiratory tract infection,16582850
1,1,22.1,Pneumonia,16582850
2,1,22.1,Pyrexia,16582850
3,1,22.1,Vestibular neuronitis,16582850
0,1,22.1,Nausea,16582867
1,6,22.1,Cough,16582867
2,3,22.1,Dyspnoea,16582867
3,1,22.1,Pneumonia,16582867
4,2,22.1,Chronic obstructive pulmonary disease,16582867
5,3,22.1,Constipation,16582867
6,1,22.1,Vomiting,16582867
7,3,22.1,Decreased appetite,16582867
8,6,22.1,Cardiovascular disorder,16582867
9,1,22.1,Urinary tract infection,16582867
10,1,22.1,Pneumonia,16582867
11,6,22.1,Thrombosis,16582867
12,1,22.1,Subileus,16582867
13,6,22.1,Vomiting,16582867
0,6,22.1,Fatigue,16582881
1,6,22.1,Gastrointestinal disorder,16582881
2,6,22.1,Asthenia,16582881
0,1,22.1,Weight decreased,16582895
1,6,22.1,Asthenia,16582895
2,6,22.1,Bone cancer metastatic,16582895
3,1,22.1,Vertigo,16582895
4,1,22.1,Gastroenteritis viral,16582895
5,6,22.1,Malaise,16582895
6,1,22.1,Dizziness,16582895
0,6,22.0,Neuropathy peripheral,16582920
1,6,22.0,Pain,16582920
2,6,22.0,Stomatitis,16582920
3,6,22.0,Vomiting,16582920
4,6,22.0,Febrile neutropenia,16582920
5,6,22.0,Constipation,16582920
6,6,22.0,Arthralgia,16582920
7,6,22.0,Dyspnoea,16582920
8,6,22.0,Anxiety,16582920
9,6,22.0,Diarrhoea,16582920
10,6,22.0,Abdominal pain,16582920
11,6,22.0,Myalgia,16582920
12,6,22.0,Hot flush,16582920
13,6,22.0,Depression,16582920
14,6,22.0,Fatigue,16582920
15,6,22.0,Insomnia,16582920
16,6,22.0,Nausea,16582920
0,6,22.0,Drug ineffective,16582978
1,3,22.0,Anaemia,16582978
0,1,22.0,Sinusitis,16583001
1,6,22.0,Off label use,16583001
0,6,22.1,Malignant neoplasm progression,16583007
1,1,22.1,Lip disorder,16583007
2,1,22.1,Radiation pneumonitis,16583007
3,6,22.1,Oxygen saturation decreased,16583007
0,6,22.0,Urinary tract infection,16583039
1,6,22.0,White blood cell count decreased,16583039
0,1,22.1,Diarrhoea,16583103
1,6,22.1,Fatigue,16583103
0,6,22.0,Ear disorder,16583105
1,6,22.0,Hypoacusis,16583105
0,6,22.1,Neoplasm progression,16583133
1,3,22.1,Neutropenia,16583133
2,3,22.1,White blood cell count decreased,16583133
0,2,22.0,Alopecia,16583147
0,1,22.0,Vomiting,16583159
1,6,22.0,Nausea,16583159
2,6,22.0,Dizziness,16583159
0,5,22.0,Infection,16583196
0,6,22.0,Inappropriate schedule of product administration,16583213
0,6,22.0,Proteinuria,16583287
1,6,22.0,Neutropenia,16583287
0,6,22.0,Loss of personal independence in daily activities,16583300
1,6,22.0,Off label use,16583300
2,6,22.0,Product use issue,16583300
0,6,22.0,Product dose omission,16583389
1,6,22.0,Neoplasm progression,16583389
2,6,22.0,Fatigue,16583389
0,6,22.1,Fatigue,16583421
1,6,22.1,Neutropenia,16583421
2,1,22.1,Anxiety,16583421
0,6,22.0,Malignant neoplasm progression,16583427
1,6,22.0,Pyrexia,16583427
2,6,22.0,Interstitial lung disease,16583427
3,6,22.0,C-reactive protein increased,16583427
0,6,22.1,Macular oedema,16583441
1,1,22.1,Eye haemorrhage,16583441
2,3,22.1,Vision blurred,16583441
3,3,22.1,Back pain,16583441
4,3,22.1,Arthralgia,16583441
5,6,22.1,Weight bearing difficulty,16583441
6,3,22.1,Memory impairment,16583441
7,6,22.1,Cataract,16583441
8,6,22.1,Gait inability,16583441
9,3,22.1,Musculoskeletal chest pain,16583441
0,5,22.0,Death,16583446
1,3,22.0,Pain in jaw,16583446
2,3,22.0,Malaise,16583446
3,3,22.0,Dehydration,16583446
4,3,22.0,Bone pain,16583446
0,6,22.1,Mastitis,16583453
1,3,22.1,Dyspepsia,16583453
2,6,22.1,Fatigue,16583453
3,6,22.1,Diarrhoea,16583453
0,,22.0,Unevaluable event,16583456
1,,22.0,Death,16583456
0,1,22.0,Liver disorder,16583463
1,6,22.0,Disseminated intravascular coagulation,16583463
0,6,22.0,Hydroureter,16583601
1,6,22.0,Neoplasm progression,16583601
2,6,22.0,Formication,16583601
3,6,22.0,Cutaneous calcification,16583601
4,6,22.0,Asthenia,16583601
5,6,22.0,Musculoskeletal stiffness,16583601
6,6,22.0,Haemoglobin decreased,16583601
7,6,22.0,General physical health deterioration,16583601
8,6,22.0,Hydronephrosis,16583601
9,6,22.0,Dyspepsia,16583601
0,3,22.0,Neuropathy peripheral,16583607
1,3,22.0,Cerebellar syndrome,16583607
0,3,22.1,Hair texture abnormal,16583610
1,3,22.1,Hair colour changes,16583610
2,3,22.1,Madarosis,16583610
3,3,22.1,Alopecia,16583610
4,3,22.1,Hair disorder,16583610
0,2,22.0,Anaphylactic shock,16583637
0,,22.0,Therapy cessation,16583652
1,,22.0,Malaise,16583652
0,,22.0,Disease progression,16583660
0,6,22.0,Neoplasm progression,16583661
0,,22.0,Fall,16583681
1,,22.0,Muscular weakness,16583681
0,6,22.1,Cognitive disorder,16583687
0,6,22.1,Neoplasm progression,16583708
1,6,22.1,Malaise,16583708
2,6,22.1,Fatigue,16583708
3,6,22.1,Upper respiratory tract infection,16583708
4,6,22.1,Burning sensation,16583708
5,6,22.1,Lung disorder,16583708
0,6,22.1,Anxiety,16583723
0,6,22.0,Somnolence,16583733
0,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16583741
1,6,22.0,Hepatic function abnormal,16583741
2,6,22.0,Gastrointestinal disorder,16583741
3,6,22.0,Bone marrow failure,16583741
4,6,22.0,Renal impairment,16583741
0,2,22.0,Acute kidney injury,16583744
1,2,22.0,Cholestasis,16583744
0,6,22.0,Neoplasm progression,16583747
1,6,22.0,Alopecia,16583747
2,6,22.0,Fatigue,16583747
3,6,22.0,White blood cell count decreased,16583747
0,6,22.0,Tongue coated,16583759
1,6,22.0,Insomnia,16583759
2,6,22.0,Aura,16583759
3,6,22.0,Nasopharyngitis,16583759
4,6,22.0,Tinnitus,16583759
5,6,22.0,Pleurisy,16583759
6,6,22.0,Chills,16583759
7,6,22.0,Oral disorder,16583759
8,6,22.0,Pyrexia,16583759
9,6,22.0,Pain,16583759
10,6,22.0,Bronchial disorder,16583759
11,1,22.0,Blood pressure increased,16583759
12,6,22.0,Aphthous ulcer,16583759
0,5,22.0,Death,16583828
0,2,22.0,Nephrotic syndrome,16583855
1,6,22.0,Bone marrow toxicity,16583855
2,2,22.0,Liver injury,16583855
3,2,22.0,Rectal cancer metastatic,16583855
0,,22.0,Death,16583862
0,5,22.0,Death,16583873
0,3,22.0,Aspartate aminotransferase increased,16583879
1,3,22.0,Hepatic enzyme increased,16583879
2,2,22.0,Decreased appetite,16583879
3,3,22.0,Alanine aminotransferase increased,16583879
4,2,22.0,Decubitus ulcer,16583879
0,,22.0,Diarrhoea,16583888
1,,22.0,Weight decreased,16583888
2,,22.0,Swelling,16583888
3,,22.0,Vomiting,16583888
0,5,22.0,Death,16584013
0,3,22.1,Neutropenia,16584053
1,1,22.1,Diarrhoea,16584053
2,6,22.1,Electrocardiogram QT prolonged,16584053
3,3,22.1,Infection,16584053
4,1,22.1,Body temperature increased,16584053
5,1,22.1,Syncope,16584053
6,1,22.1,Clostridium difficile infection,16584053
7,1,22.1,Swelling face,16584053
0,4,22.0,Septic shock,16584061
1,4,22.0,Neutropenic colitis,16584061
0,2,22.0,Platelet count decreased,16584117
1,6,22.0,Gastrointestinal haemorrhage,16584117
0,6,22.0,Acute kidney injury,16584119
1,6,22.0,Chronic kidney disease,16584119
2,6,22.0,Nephropathy toxic,16584119
0,3,22.0,Depression,16584162
1,6,22.0,Product dose omission,16584162
2,3,22.0,Hernia,16584162
3,6,22.0,Product availability issue,16584162
0,6,22.0,Malignant neoplasm progression,16584184
1,6,22.0,Drug resistance,16584184
0,6,22.0,Traumatic lung injury,16584237
0,1,22.1,Cholestasis,16584257
0,6,22.0,Prostatic specific antigen increased,16584325
1,5,22.0,Pneumonitis,16584325
2,6,22.0,Drug ineffective,16584325
0,1,22.0,Anaemia,16584415
0,1,22.0,Pain in extremity,16584444
1,,22.0,Blood magnesium decreased,16584444
2,3,22.0,Decreased appetite,16584444
3,3,22.0,Blood pressure increased,16584444
4,1,22.0,Hypoaesthesia,16584444
5,3,22.0,Flatulence,16584444
6,1,22.0,Fatigue,16584444
7,3,22.0,Hepatic cancer,16584444
8,1,22.0,Chills,16584444
9,3,22.0,Protein urine present,16584444
10,1,22.0,Paraesthesia,16584444
11,3,22.0,Fatigue,16584444
12,,22.0,Off label use,16584444
13,3,22.0,Neuropathy peripheral,16584444
14,1,22.0,Pyrexia,16584444
15,1,22.0,Headache,16584444
0,6,22.0,Prescribed underdose,16584445
1,6,22.0,Circumstance or information capable of leading to medication error,16584445
2,5,22.0,Depressed level of consciousness,16584445
3,6,22.0,Device failure,16584445
0,3,22.0,Hypoaesthesia,16584513
1,3,22.0,Demyelinating polyneuropathy,16584513
0,6,22.0,Stomatitis,16584529
1,6,22.0,Diarrhoea,16584529
2,6,22.0,Gastrointestinal motility disorder,16584529
3,6,22.0,Oral discomfort,16584529
0,3,22.0,Nail disorder,16584547
0,3,22.0,Stomatitis,16584552
1,3,22.0,Diarrhoea,16584552
2,3,22.0,Nail discolouration,16584552
3,3,22.0,Tachycardia,16584552
4,3,22.0,Asthenia,16584552
5,3,22.0,Pyrexia,16584552
0,5,22.0,Hepatic cirrhosis,16584555
1,5,22.0,Hepatic function abnormal,16584555
0,,22.0,Hypertension,16584561
1,,22.0,Dry mouth,16584561
2,,22.0,Dyspnoea,16584561
3,,22.0,Therapy cessation,16584561
4,,22.0,Diarrhoea,16584561
0,6,22.0,Off label use,16584578
1,6,22.0,Malignant neoplasm progression,16584578
2,5,22.0,Death,16584578
3,6,22.0,Ascites,16584578
0,1,22.0,Hepatocellular injury,16584581
0,1,22.0,Abdominal pain upper,16584584
1,1,22.0,Headache,16584584
2,1,22.0,Nausea,16584584
3,1,22.0,Hypotension,16584584
4,1,22.0,Hyperhidrosis,16584584
0,2,22.0,Hepatic function abnormal,16584588
0,6,22.1,Product dose omission,16584598
1,6,22.1,Bladder cancer recurrent,16584598
0,2,22.0,Pneumonia bacterial,16584600
1,2,22.0,Cataract,16584600
2,6,22.0,Anaemia,16584600
3,2,22.0,Interstitial lung disease,16584600
0,2,22.1,Neutropenia,16584611
0,2,22.0,Ascites,16584612
0,6,22.0,Drug ineffective,16584633
0,,22.0,Dysgeusia,16584645
0,1,22.0,Prostate cancer metastatic,16584678
0,6,22.0,Neuropathy peripheral,16584737
1,6,22.0,Hypertension,16584737
2,6,22.0,Proteinuria,16584737
3,6,22.0,Skin toxicity,16584737
0,6,22.0,Dry mouth,16584767
1,6,22.0,Dry throat,16584767
2,6,22.0,Dry skin,16584767
3,6,22.0,Blood glucose increased,16584767
4,6,22.0,Asthenia,16584767
5,6,22.0,Decreased appetite,16584767
6,6,22.0,Renal disorder,16584767
7,6,22.0,Lacrimation increased,16584767
8,6,22.0,Ageusia,16584767
0,,22.0,Blood sodium decreased,16584772
1,,22.0,Fall,16584772
2,,22.0,Blood potassium decreased,16584772
0,1,22.1,Neutropenia,16584795
1,1,22.1,Electrocardiogram T wave abnormal,16584795
2,1,22.1,Mitral valve incompetence,16584795
3,6,22.1,Weight decreased,16584795
4,1,22.1,Eastern Cooperative Oncology Group performance status worsened,16584795
0,6,22.0,Nephritis,16584852
0,6,22.0,Gastrooesophageal reflux disease,16584858
1,1,22.0,Sepsis,16584858
0,2,22.0,Febrile neutropenia,16584862
0,2,22.0,Pyrexia,16584877
1,2,22.0,Erythema,16584877
2,1,22.0,Breast discharge,16584877
3,3,22.0,White blood cell count increased,16584877
4,6,22.0,Haemoglobin decreased,16584877
5,2,22.0,Breast enlargement,16584877
6,3,22.0,Neutrophil count decreased,16584877
7,6,22.0,Paget^s disease of nipple,16584877
8,2,22.0,Breast pain,16584877
9,6,22.0,Nipple inflammation,16584877
10,6,22.0,Breast tenderness,16584877
11,6,22.0,Red blood cell count decreased,16584877
12,3,22.0,Urticaria,16584877
0,2,22.1,Infection,16584879
1,1,22.1,Klebsiella sepsis,16584879
2,1,22.1,Sepsis,16584879
3,1,22.1,Pneumonia klebsiella,16584879
4,3,22.1,Pyrexia,16584879
0,1,22.0,Pathological fracture,16584918
1,3,22.0,Osteolysis,16584918
0,6,22.0,Haematotoxicity,16584922
1,3,22.0,Skin lesion,16584922
2,3,22.0,Disease progression,16584922
3,5,22.0,Death,16584922
4,6,22.0,General physical health deterioration,16584922
5,6,22.0,Off label use,16584922
6,6,22.0,Infection,16584922
0,6,22.0,Neurotoxicity,16584959
1,6,22.0,Feeling cold,16584959
0,6,22.0,Neurotoxicity,16584961
1,6,22.0,Feeling cold,16584961
0,6,22.1,White blood cell disorder,16584973
1,6,22.1,Malaise,16584973
2,6,22.1,Red blood cell count abnormal,16584973
3,6,22.1,White blood cell count decreased,16584973
4,6,22.1,Immunodeficiency,16584973
0,3,22.0,Skin ulcer,16585095
1,3,22.0,Ischaemia,16585095
0,5,22.0,Pneumonia,16585124
0,2,22.0,Platelet count decreased,16585275
1,6,22.0,Fall,16585275
2,1,22.0,Haemoglobin decreased,16585275
3,6,22.0,Emotional distress,16585275
4,3,22.0,Dry mouth,16585275
5,1,22.0,Platelet count decreased,16585275
6,3,22.0,Weight increased,16585275
7,2,22.0,Asthenia,16585275
8,3,22.0,Decreased appetite,16585275
9,1,22.0,Nausea,16585275
10,1,22.0,Fatigue,16585275
11,1,22.0,Dyspnoea,16585275
12,3,22.0,Lip dry,16585275
13,1,22.0,Headache,16585275
14,3,22.0,Constipation,16585275
15,6,22.0,Full blood count decreased,16585275
16,3,22.0,Hypertension,16585275
17,3,22.0,Feeling abnormal,16585275
0,6,22.0,Intestinal perforation,16585291
1,6,22.0,Malaise,16585291
2,5,22.0,Sepsis,16585291
3,6,22.0,Cyanosis,16585291
4,6,22.0,Feeling cold,16585291
5,6,22.0,Hyperhidrosis,16585291
6,6,22.0,Diarrhoea,16585291
7,6,22.0,Gait disturbance,16585291
8,6,22.0,Dyspnoea,16585291
9,6,22.0,Fatigue,16585291
0,1,22.1,Blood pressure increased,16585301
1,1,22.1,Decreased appetite,16585301
2,1,22.1,Infected dermal cyst,16585301
3,6,22.1,Hypertension,16585301
0,5,22.0,Death,16585419
0,6,22.1,C-reactive protein increased,16585592
1,2,22.1,Interstitial lung disease,16585592
0,1,22.0,Intestinal ischaemia,16585646
1,6,22.0,Postoperative adhesion,16585646
2,6,22.0,Abdominal pain,16585646
0,1,22.1,Unevaluable event,16585675
1,6,22.1,Rhinorrhoea,16585675
2,6,22.1,Fatigue,16585675
3,6,22.1,Nausea,16585675
4,3,22.1,Idiopathic intracranial hypertension,16585675
5,6,22.1,Taste disorder,16585675
0,,22.0,Gait inability,16585685
1,3,22.0,Abdominal discomfort,16585685
2,3,22.0,Muscle spasms,16585685
3,,22.0,Chills,16585685
4,3,22.0,Fatigue,16585685
5,,22.0,Off label use,16585685
6,1,22.0,Muscle spasms,16585685
7,2,22.0,Pyrexia,16585685
8,,22.0,Performance status decreased,16585685
9,,22.0,Feeling cold,16585685
10,,22.0,Heart rate increased,16585685
11,,22.0,Colorectal cancer,16585685
12,3,22.0,Fatigue,16585685
0,6,22.1,Bladder cancer recurrent,16585686
1,6,22.1,Product availability issue,16585686
0,1,22.0,Cholangitis sclerosing,16585891
0,5,22.0,Death,16585941
1,6,22.0,Pruritus,16585941
2,6,22.0,Rash,16585941
0,6,22.0,Nausea,16585980
0,3,22.0,Decreased appetite,16586050
1,3,22.0,Diarrhoea,16586050
2,3,22.0,Taste disorder,16586050
3,3,22.0,Blood count abnormal,16586050
0,6,22.0,Intestinal obstruction,16586057
0,2,22.0,Pain in extremity,16586064
1,3,22.0,Blister,16586064
2,2,22.0,Faeces soft,16586064
3,3,22.0,Constipation,16586064
4,6,22.0,Product dose omission,16586064
5,3,22.0,Neuropathy peripheral,16586064
0,6,22.0,Liver function test increased,16586087
0,5,22.0,Death,16586105
0,6,22.0,Syncope,16586132
1,6,22.0,Diarrhoea,16586132
2,3,22.0,Malaise,16586132
3,3,22.0,Dehydration,16586132
4,6,22.0,Muscular weakness,16586132
5,1,22.0,Appetite disorder,16586132
6,6,22.0,Nausea,16586132
7,3,22.0,Arthralgia,16586132
8,6,22.0,Vomiting,16586132
9,6,22.0,White blood cell count decreased,16586132
10,6,22.0,Fall,16586132
11,6,22.0,Disease progression,16586132
12,3,22.0,Cough,16586132
13,6,22.0,Weight decreased,16586132
14,6,22.0,Pain in extremity,16586132
15,6,22.0,Muscle spasms,16586132
16,6,22.0,Cataract,16586132
17,6,22.0,Red blood cell count decreased,16586132
18,6,22.0,Constipation,16586132
19,6,22.0,Back pain,16586132
20,6,22.0,Blood pressure fluctuation,16586132
0,6,22.0,Aspartate aminotransferase increased,16586165
1,6,22.0,Alanine aminotransferase increased,16586165
2,5,22.0,Disease progression,16586165
3,6,22.0,Blood bilirubin increased,16586165
0,5,22.0,Death,16586190
0,5,22.0,Death,16586206
0,2,22.1,White blood cell count decreased,16586211
1,6,22.1,Sleep disorder,16586211
2,6,22.1,Flushing,16586211
3,1,22.1,Hypokalaemia,16586211
4,6,22.1,Alopecia,16586211
5,2,22.1,Blood potassium decreased,16586211
6,6,22.1,Neuropathy peripheral,16586211
7,1,22.1,Bone marrow failure,16586211
8,1,22.1,Pneumonia,16586211
9,6,22.1,Dry skin,16586211
10,1,22.1,Pain of skin,16586211
11,1,22.1,Muscle spasms,16586211
12,6,22.1,Cardiac failure congestive,16586211
13,6,22.1,Hot flush,16586211
14,2,22.1,Fatigue,16586211
15,1,22.1,Respiratory disorder,16586211
0,6,22.0,Dizziness,16586218
1,6,22.0,Chills,16586218
2,6,22.0,Pain of skin,16586218
3,1,22.0,Diarrhoea,16586218
4,6,22.0,Pyrexia,16586218
5,3,22.0,Alopecia,16586218
6,6,22.0,Skin discolouration,16586218
7,6,22.0,Asthenia,16586218
8,3,22.0,Hypertension,16586218
9,6,22.0,Dehydration,16586218
10,1,22.0,Constipation,16586218
11,6,22.0,Vision blurred,16586218
0,3,22.1,Sensory disturbance,16586222
1,6,22.1,Dyspnoea exertional,16586222
2,2,22.1,Leukopenia,16586222
3,1,22.1,Thrombocytopenia,16586222
4,6,22.1,Oedema peripheral,16586222
5,6,22.1,Blood pressure systolic increased,16586222
6,6,22.1,Pulmonary valve incompetence,16586222
7,6,22.1,Tricuspid valve incompetence,16586222
8,3,22.1,Dry mouth,16586222
9,6,22.1,Blood potassium increased,16586222
10,6,22.1,Chest pain,16586222
11,6,22.1,Supraventricular extrasystoles,16586222
12,3,22.1,Dizziness,16586222
13,6,22.1,Supraventricular tachycardia,16586222
14,6,22.1,Electrocardiogram QT prolonged,16586222
15,6,22.1,Myocardial infarction,16586222
16,6,22.1,Sinus bradycardia,16586222
17,6,22.1,Arrhythmia,16586222
18,6,22.1,Pulmonary embolism,16586222
0,1,22.0,Infusion related reaction,16586226
0,5,22.0,Death,16586261
0,2,22.0,Tubulointerstitial nephritis,16586268
1,2,22.0,Cholestasis,16586268
0,5,22.0,Death,16586282
0,1,22.0,Pyrexia,16586313
1,6,22.0,Toxic skin eruption,16586313
0,6,22.0,Breast cancer,16586331
1,6,22.0,Malignant neoplasm progression,16586331
0,,22.0,Fall,16586340
1,,22.0,Traumatic fracture,16586340
0,6,22.0,Pulmonary hypertension,16586343
1,6,22.0,Malignant neoplasm progression,16586343
0,1,22.0,Infusion related reaction,16586347
1,6,22.0,Feeling hot,16586347
2,6,22.0,Chest discomfort,16586347
3,6,22.0,Erythema,16586347
4,6,22.0,Dyspnoea,16586347
5,6,22.0,Hypotension,16586347
6,6,22.0,Abdominal pain upper,16586347
0,6,22.0,Extrasystoles,16586352
1,6,22.0,Infusion related reaction,16586352
2,6,22.0,Malaise,16586352
3,6,22.0,Hypotension,16586352
0,6,22.0,Pyrexia,16586353
1,6,22.0,Mucosal disorder,16586353
2,6,22.0,Pneumonia,16586353
3,6,22.0,Aphonia,16586353
0,3,22.0,Asthenia,16586375
1,2,22.0,C-reactive protein increased,16586375
2,2,22.0,Hyperferritinaemia,16586375
3,3,22.0,Neutrophilia,16586375
4,6,22.0,Decreased appetite,16586375
5,1,22.0,Hyperthermia,16586375
6,3,22.0,Still^s disease,16586375
0,3,22.0,Chest pain,16586376
1,3,22.0,Pericarditis,16586376
2,3,22.0,Pleural effusion,16586376
0,1,22.0,Pneumonia staphylococcal,16586404
1,1,22.0,Sepsis,16586404
0,6,22.1,Drug resistance,16586405
1,6,22.1,Malignant neoplasm progression,16586405
2,6,22.1,Neuropathy peripheral,16586405
0,6,22.0,Cardiac disorder,16586426
0,1,22.1,Hypertension,16586499
0,1,22.0,Hypophysitis,16586515
0,1,22.1,Pneumonia,16586530
1,1,22.1,Acute myocardial infarction,16586530
0,5,22.0,Death,16586539
1,1,22.0,Diarrhoea,16586539
0,1,22.0,Drug-induced liver injury,16586579
0,6,22.1,Infarction,16586592
1,1,22.1,Wound,16586592
2,3,22.1,Malaise,16586592
3,3,22.1,Pyrexia,16586592
4,6,22.1,Hypersensitivity,16586592
5,3,22.1,Chills,16586592
6,6,22.1,Neck pain,16586592
7,6,22.1,Depressed mood,16586592
8,6,22.1,Laboratory test abnormal,16586592
9,6,22.1,Pain,16586592
10,6,22.1,Asthenia,16586592
0,6,22.0,Dyspnoea,16586631
1,6,22.0,Neutropenia,16586631
2,6,22.0,Asthenia,16586631
0,1,22.0,Pyrexia,16586708
1,2,22.0,Jaundice,16586708
0,2,22.0,Rash erythematous,16586727
1,3,22.0,Dermatitis bullous,16586727
2,6,22.0,Injection site discolouration,16586727
0,3,22.0,Posterior reversible encephalopathy syndrome,16586810
0,1,22.1,Pneumonia,16586814
0,6,22.0,Impaired quality of life,16586826
1,2,22.0,Alopecia,16586826
2,6,22.0,Anxiety,16586826
3,6,22.0,Emotional distress,16586826
4,6,22.0,Pain,16586826
5,6,22.0,Psychological trauma,16586826
0,6,22.0,Product administration error,16586854
0,6,22.0,Psychological trauma,16586863
1,2,22.0,Alopecia,16586863
0,6,22.1,Psychological trauma,16586865
1,2,22.1,Alopecia,16586865
0,3,22.0,Alopecia,16586866
1,6,22.0,Anxiety,16586866
2,6,22.0,Pain,16586866
3,6,22.0,Impaired quality of life,16586866
4,6,22.0,Emotional distress,16586866
5,6,22.0,Psychological trauma,16586866
0,6,22.0,Nausea,16586868
1,6,22.0,Rash,16586868
2,6,22.0,Pharyngeal swelling,16586868
0,2,22.0,Interstitial lung disease,16586875
0,6,22.0,Stevens-Johnson syndrome,16586888
0,2,22.1,Alopecia,16586891
1,6,22.1,Psychological trauma,16586891
0,6,22.0,White blood cell count decreased,16586892
0,2,22.0,Alopecia,16586905
1,6,22.0,Pain,16586905
2,6,22.0,Impaired quality of life,16586905
3,6,22.0,Psychological trauma,16586905
4,6,22.0,Emotional distress,16586905
5,6,22.0,Anxiety,16586905
0,6,22.0,Psychological trauma,16586919
1,2,22.0,Alopecia,16586919
0,1,22.1,Nephrolithiasis,16586929
1,3,22.1,Pyelonephritis,16586929
0,4,22.0,Septic shock,16586978
1,4,22.0,Neutropenic colitis,16586978
0,3,22.0,Haemorrhage,16587023
1,3,22.0,Localised infection,16587023
2,3,22.0,Onycholysis,16587023
0,6,22.1,Product use complaint,16587049
1,3,22.1,Oesophageal disorder,16587049
0,3,22.0,Arrhythmia supraventricular,16587061
1,1,22.0,Cardiac failure,16587061
0,6,22.0,Rash pruritic,16587066
0,6,22.0,Product prescribing error,16587079
1,6,22.0,Product packaging issue,16587079
0,2,22.0,Immune reconstitution inflammatory syndrome,16587083
0,3,22.0,Personality change,16587092
1,3,22.0,Feeling abnormal,16587092
2,3,22.0,Flat affect,16587092
3,3,22.0,Mood altered,16587092
4,3,22.0,Apathy,16587092
0,6,22.0,Liver function test abnormal,16587093
0,6,22.0,Hyperaesthesia teeth,16587099
1,6,22.0,Toothache,16587099
0,1,22.1,Rash,16587120
1,6,22.1,Nausea,16587120
2,1,22.1,Pruritus,16587120
3,6,22.1,Weight decreased,16587120
0,6,22.0,Off label use,16587127
1,6,22.0,Product packaging quantity issue,16587127
2,6,22.0,Incorrect dose administered,16587127
0,6,22.0,Cough,16587130
1,6,22.0,Decreased appetite,16587130
2,6,22.0,Muscle atrophy,16587130
3,6,22.0,Fatigue,16587130
4,6,22.0,Hot flush,16587130
5,6,22.0,Flatulence,16587130
6,6,22.0,Dizziness,16587130
7,6,22.0,Balance disorder,16587130
8,6,22.0,Abdominal pain upper,16587130
9,6,22.0,Nausea,16587130
0,2,22.0,Alopecia,16587148
1,6,22.0,Psychological trauma,16587148
0,6,22.0,Hormone level abnormal,16587247
1,6,22.0,Musculoskeletal stiffness,16587247
2,6,22.0,Myalgia,16587247
3,6,22.0,Arthralgia,16587247
4,2,22.0,Pain,16587247
5,2,22.0,Dizziness,16587247
0,6,22.1,Asthenia,16587252
1,6,22.1,Carbohydrate antigen 15-3 increased,16587252
2,6,22.1,Pain in extremity,16587252
3,2,22.1,Psoriasis,16587252
4,6,22.1,Neutrophil count decreased,16587252
5,6,22.1,Dizziness,16587252
6,6,22.1,Dyspnoea,16587252
7,6,22.1,Arthralgia,16587252
8,2,22.1,Dyspepsia,16587252
9,6,22.1,Anxiety,16587252
10,6,22.1,Irritability,16587252
11,6,22.1,Fatigue,16587252
12,6,22.1,Limb discomfort,16587252
13,6,22.1,Malaise,16587252
14,1,22.1,Blood pressure decreased,16587252
0,6,22.0,Haemoglobin decreased,16587289
1,6,22.0,Haematuria,16587289
0,6,22.0,Overdose,16587294
1,6,22.0,Product storage error,16587294
0,4,22.0,Septic shock,16587372
1,1,22.0,Pancytopenia,16587372
0,5,22.0,Death,16587418
0,6,22.0,Lethargy,16587428
1,6,22.0,Confusional state,16587428
2,6,22.0,Drug ineffective,16587428
0,3,22.0,Dysphagia,16587435
0,6,22.1,Product dose omission,16587495
1,3,22.1,Inappropriate schedule of product administration,16587495
2,3,22.1,Wrong technique in product usage process,16587495
3,3,22.1,Hospitalisation,16587495
4,6,22.1,Urinary tract infection,16587495
5,3,22.1,Product use complaint,16587495
0,6,22.0,Metastatic carcinoma of the bladder,16587505
0,1,22.0,Ejection fraction decreased,16587525
1,3,22.0,Fatigue,16587525
2,3,22.0,Alopecia,16587525
3,1,22.0,Cellulitis,16587525
4,1,22.0,Hypokalaemia,16587525
5,3,22.0,Pain in extremity,16587525
0,3,22.1,Bladder obstruction,16587575
1,6,22.1,Musculoskeletal disorder,16587575
2,3,22.1,Bladder disorder,16587575
0,5,22.0,Death,16587620
0,3,22.1,Nausea,16587633
1,3,22.1,Fatigue,16587633
2,6,22.1,Dysarthria,16587633
3,3,22.1,Memory impairment,16587633
4,6,22.1,Balance disorder,16587633
5,6,22.1,Fall,16587633
6,3,22.1,Rash pruritic,16587633
7,6,22.1,Confusional state,16587633
0,1,22.0,Hypersensitivity,16587679
1,1,22.0,Back pain,16587679
0,1,22.0,Neutropenia,16587794
1,1,22.0,Haematotoxicity,16587794
2,1,22.0,Sepsis,16587794
3,1,22.0,Loss of personal independence in daily activities,16587794
0,3,22.0,Diarrhoea,16587808
1,3,22.0,Dehydration,16587808
2,3,22.0,Dysuria,16587808
3,3,22.0,Vomiting,16587808
4,3,22.0,Decreased appetite,16587808
0,6,22.1,Decreased activity,16587809
1,6,22.1,Diarrhoea,16587809
2,6,22.1,Urinary tract infection,16587809
3,1,22.1,Nausea,16587809
4,6,22.1,Off label use,16587809
5,1,22.1,Diarrhoea,16587809
6,1,22.1,Ileus,16587809
7,1,22.1,Pyrexia,16587809
0,3,22.1,Anaemia,16587846
1,6,22.1,Skin haemorrhage,16587846
2,6,22.1,Dizziness,16587846
3,6,22.1,Confusional state,16587846
4,3,22.1,Hypocalcaemia,16587846
5,6,22.1,Hypotension,16587846
6,3,22.1,Diarrhoea,16587846
7,3,22.1,Panic attack,16587846
8,6,22.1,Blood pressure increased,16587846
9,3,22.1,Abdominal discomfort,16587846
10,6,22.1,Nausea,16587846
11,3,22.1,Anxiety,16587846
12,3,22.1,Amnesia,16587846
13,6,22.1,Skin exfoliation,16587846
14,6,22.1,Gingivitis,16587846
15,6,22.1,Sensitive skin,16587846
16,6,22.1,Dry skin,16587846
17,6,22.1,Decreased appetite,16587846
18,6,22.1,Vomiting,16587846
19,6,22.1,Gingival bleeding,16587846
20,6,22.1,Fall,16587846
0,6,22.0,Product storage error,16587897
0,6,22.0,Lymphadenectomy,16588008
0,3,22.1,Blood potassium increased,16588040
1,6,22.1,Diarrhoea,16588040
0,4,22.1,Tendonitis,16588101
0,6,22.0,PIK3CA-activated mutation,16588107
1,6,22.0,Oestrogen receptor positive breast cancer,16588107
2,6,22.0,Malignant neoplasm progression,16588107
3,6,22.0,Breast cancer metastatic,16588107
0,1,22.1,No adverse event,16588110
0,6,22.0,Hyponatraemia,16588114
0,5,22.0,Neurological decompensation,16588119
1,6,22.0,Neoplasm progression,16588119
2,1,22.0,Headache,16588119
3,6,22.0,Metastases to central nervous system,16588119
4,3,22.0,General physical health deterioration,16588119
5,1,22.0,Vomiting,16588119
0,6,22.0,Pulmonary toxicity,16588120
0,6,22.0,Pulmonary toxicity,16588121
0,3,22.0,Skin disorder,16588175
1,3,22.0,Stoma site infection,16588175
0,5,22.0,Death,16588185
0,6,22.0,Hair colour changes,16588278
1,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16588278
2,6,22.0,Neuropathy peripheral,16588278
3,6,22.0,Constipation,16588278
4,6,22.0,Diarrhoea,16588278
0,6,22.0,Malignant neoplasm progression,16588293
1,6,22.0,Drug resistance,16588293
0,6,22.0,Myelodysplastic syndrome,16588318
0,3,22.0,Pneumonitis,16588377
0,6,22.0,Fall,16588397
1,2,22.0,Wound,16588397
0,3,22.0,Intestinal haemorrhage,16588401
0,3,22.1,Renal surgery,16588415
1,3,22.1,Hot flush,16588415
2,6,22.1,Prostatic specific antigen abnormal,16588415
3,3,22.1,Blood testosterone increased,16588415
0,1,22.0,Anaphylactic shock,16588470
0,2,22.0,Hypocalcaemia,16588476
1,2,22.0,Hypomagnesaemia,16588476
2,2,22.0,Hypokalaemia,16588476
3,3,22.0,Diarrhoea,16588476
4,6,22.0,Off label use,16588476
0,3,22.0,Hepatitis,16588479
0,1,22.0,Cholestasis,16588481
0,1,22.0,Ventricular tachycardia,16588484
1,1,22.0,Acute coronary syndrome,16588484
0,2,22.0,Urinary tract infection,16588494
1,2,22.0,Dehydration,16588494
2,2,22.0,Platelet count decreased,16588494
0,5,22.0,Death,16588505
1,6,22.0,Acute hepatic failure,16588505
2,6,22.0,Pain,16588505
3,6,22.0,Erythema,16588505
4,6,22.0,Urinary tract infection,16588505
0,5,22.1,Malignant neoplasm progression,16588530
1,6,22.1,Adverse event,16588530
2,6,22.1,Pyrexia,16588530
3,6,22.1,Pneumonitis,16588530
0,1,22.1,Chondritis,16588535
0,6,22.0,Hepatitis B surface antibody positive,16588592
0,3,22.1,Neuropathy peripheral,16588634
1,1,22.1,Pain in extremity,16588634
2,2,22.1,Leukopenia,16588634
3,6,22.1,Headache,16588634
4,6,22.1,Pain,16588634
5,6,22.1,Dysphagia,16588634
6,1,22.1,Cough,16588634
7,1,22.1,Oropharyngeal pain,16588634
8,3,22.1,Neutropenia,16588634
9,6,22.1,Nausea,16588634
10,6,22.1,Fatigue,16588634
11,6,22.1,Bone marrow failure,16588634
12,1,22.1,Pyrexia,16588634
13,6,22.1,Restlessness,16588634
0,1,22.0,Urinary tract infection,16588638
1,6,22.0,Decreased appetite,16588638
2,6,22.0,Gait disturbance,16588638
3,2,22.0,Nausea,16588638
4,6,22.0,Pain in extremity,16588638
5,6,22.0,Pharyngeal ulceration,16588638
6,6,22.0,Neoplasm progression,16588638
7,1,22.0,Vomiting,16588638
8,6,22.0,Peripheral swelling,16588638
9,6,22.0,Pyrexia,16588638
10,6,22.0,Arthralgia,16588638
11,2,22.0,Hyponatraemia,16588638
12,6,22.0,Stomatitis,16588638
13,6,22.0,Dysphagia,16588638
14,6,22.0,Sensation of foreign body,16588638
15,1,22.0,Diarrhoea,16588638
0,3,22.1,Platelet count decreased,16588656
1,5,22.1,Immune thrombocytopenic purpura,16588656
0,1,22.0,Diabetes mellitus,16588657
0,1,22.0,Gait disturbance,16588682
0,6,22.0,Haemorrhage,16588766
1,6,22.0,Large intestine perforation,16588766
2,6,22.0,Large intestinal obstruction,16588766
0,6,22.0,Bone marrow failure,16588767
1,6,22.0,Cardiotoxicity,16588767
0,6,22.0,Colitis,16588797
1,6,22.0,Febrile neutropenia,16588797
2,6,22.0,Diarrhoea,16588797
3,6,22.0,Nephritis,16588797
0,6,22.0,Dental care,16588821
0,6,22.1,Drug ineffective,16588834
1,2,22.1,Hypertrichosis,16588834
0,1,22.0,Neutropenia,16588944
0,3,22.0,Drug resistance,16588991
1,5,22.0,Malignant neoplasm progression,16588991
0,2,22.0,Bone pain,16588998
1,2,22.0,Cardiac disorder,16588998
0,6,22.0,Malignant neoplasm progression,16589004
1,3,22.0,Prostatic specific antigen increased,16589004
2,3,22.0,Drug resistance,16589004
0,6,22.0,Malaise,16589100
1,6,22.0,Infusion related reaction,16589100
2,6,22.0,Extrasystoles,16589100
3,6,22.0,Hypotension,16589100
0,1,22.0,Haematochezia,16589130
1,6,22.0,Fatigue,16589130
2,6,22.0,Anaemia,16589130
3,1,22.0,Gastrointestinal ulcer,16589130
4,1,22.0,Fistula of small intestine,16589130
5,6,22.0,Off label use,16589130
6,1,22.0,Gastric disorder,16589130
0,6,22.0,Epilepsy,16589140
0,6,22.1,Diarrhoea,16589141
1,6,22.1,Nocturia,16589141
2,6,22.1,Nausea,16589141
3,6,22.1,Vomiting,16589141
4,6,22.1,Malignant neoplasm progression,16589141
5,6,22.1,Constipation,16589141
6,6,22.1,Fatigue,16589141
0,3,22.0,Cerebellar syndrome,16589148
1,3,22.0,Neuropathy peripheral,16589148
0,3,22.0,Impaired healing,16589161
1,6,22.0,Autoimmune thyroiditis,16589161
2,6,22.0,Metastases to bone,16589161
3,6,22.0,Cardiac aneurysm,16589161
4,6,22.0,Spinal stenosis,16589161
5,6,22.0,Intervertebral disc protrusion,16589161
6,6,22.0,Postoperative wound infection,16589161
7,6,22.0,Odontogenic cyst,16589161
8,2,22.0,Post procedural fever,16589161
9,6,22.0,Osteonecrosis of jaw,16589161
0,5,22.0,Death,16589166
0,5,22.0,Death,16589182
1,6,22.0,Failure to thrive,16589182
0,6,22.0,Fatigue,16589206
1,6,22.0,Intestinal obstruction,16589206
2,6,22.0,Hypertension,16589206
3,6,22.0,Nausea,16589206
4,6,22.0,Vomiting,16589206
5,6,22.0,Diarrhoea,16589206
6,6,22.0,Neutropenia,16589206
0,1,22.0,Rash,16589208
0,1,22.1,Pulpitis dental,16589240
1,3,22.1,Neuropathy peripheral,16589240
2,1,22.1,Venous thrombosis limb,16589240
3,1,22.1,Mouth ulceration,16589240
4,3,22.1,Fatigue,16589240
5,3,22.1,Oedema,16589240
6,3,22.1,Malaise,16589240
0,1,22.0,Pneumatosis intestinalis,16589243
0,3,22.0,Asthenia,16589272
1,3,22.0,Stomatitis,16589272
2,3,22.0,Tachycardia,16589272
3,3,22.0,Nail discolouration,16589272
4,3,22.0,Pyrexia,16589272
5,3,22.0,Diarrhoea,16589272
0,1,22.0,Neutropenia,16589277
1,3,22.0,Leukopenia,16589277
2,3,22.0,Ovarian enlargement,16589277
0,2,22.1,Focal segmental glomerulosclerosis,16589279
0,6,22.0,Diarrhoea,16589333
1,6,22.0,Nausea,16589333
2,6,22.0,Oral pain,16589333
3,6,22.0,Dysgeusia,16589333
4,6,22.0,Fatigue,16589333
5,6,22.0,Leukopenia,16589333
6,6,22.0,Bone marrow failure,16589333
7,6,22.0,Neutropenia,16589333
8,6,22.0,Thrombocytopenia,16589333
0,5,22.0,Death,16589396
0,6,22.0,Off label use,16589411
1,5,22.0,Death,16589411
0,5,22.0,Death,16589415
0,5,22.1,Cerebrovascular accident,16589441
1,6,22.1,Nervous system disorder,16589441
0,6,22.1,Colon cancer,16589461
1,1,22.1,Pneumonia,16589461
2,6,22.1,Malignant neoplasm progression,16589461
3,1,22.1,Inguinal hernia,16589461
4,2,22.1,Cardiac failure,16589461
0,5,22.0,Pneumonitis,16589463
1,5,22.0,Pneumonia,16589463
0,6,22.0,Anal incontinence,16589472
1,6,22.0,Gastrointestinal wall thickening,16589472
2,6,22.0,Oedema,16589472
3,6,22.0,Nocturia,16589472
4,6,22.0,Bone marrow failure,16589472
5,6,22.0,Intestinal obstruction,16589472
6,6,22.0,Ascites,16589472
7,6,22.0,Herpes virus infection,16589472
8,6,22.0,Dyschezia,16589472
9,6,22.0,Pelvic fluid collection,16589472
10,6,22.0,Gastrointestinal disorder,16589472
0,6,22.0,Terminal state,16589493
0,1,22.0,Hypersensitivity,16589495
1,1,22.0,Back pain,16589495
0,5,22.0,Prostate cancer,16589525
1,5,22.0,Non-small cell lung cancer metastatic,16589525
2,5,22.0,Hormone-refractory prostate cancer,16589525
0,1,22.0,Paraesthesia,16589527
1,1,22.0,Chills,16589527
0,1,22.0,Pharyngeal oedema,16589534
1,1,22.0,Oedema mouth,16589534
0,1,22.0,Throat irritation,16589535
1,1,22.0,Feeling cold,16589535
2,1,22.0,Rash,16589535
0,5,22.0,Prostate cancer,16589553
1,6,22.0,Gait inability,16589553
2,6,22.0,Muscular weakness,16589553
0,6,22.0,Lymphadenopathy,16589558
1,2,22.0,Haematotoxicity,16589558
2,6,22.0,Ill-defined disorder,16589558
3,2,22.0,Neurotoxicity,16589558
4,6,22.0,Paronychia,16589558
5,6,22.0,Gastrointestinal disorder,16589558
6,2,22.0,Gastroenteritis radiation,16589558
7,6,22.0,Pulmonary cavitation,16589558
8,6,22.0,Bone marrow failure,16589558
9,6,22.0,Rash,16589558
0,1,22.0,Anaphylactic shock,16589574
0,1,22.0,Cardiac failure,16589577
1,3,22.0,Arrhythmia supraventricular,16589577
0,6,22.0,Cardiotoxicity,16589623
0,6,22.0,Cardiotoxicity,16589638
0,6,22.0,Cardiotoxicity,16589841
0,6,22.0,Neoplasm recurrence,16589844
1,6,22.0,Therapeutic response decreased,16589844
0,3,22.0,Epilepsy,16589851
1,6,22.0,Lung infection,16589851
2,6,22.0,Heart rate increased,16589851
3,3,22.0,Hypertension,16589851
0,6,22.0,Renal impairment,16589858
1,2,22.0,Renal impairment,16589858
2,6,22.0,Urinary tract infection,16589858
3,6,22.0,Blood creatinine increased,16589858
4,6,22.0,Malignant neoplasm progression,16589858
5,6,22.0,Urinary tract infection,16589858
6,1,22.0,Dermatitis,16589858
7,6,22.0,Urinary tract infection,16589858
8,2,22.0,Urinary tract infection bacterial,16589858
9,6,22.0,Urinary tract infection,16589858
0,1,22.1,Hyponatraemia,16589914
0,,22.0,Disease progression,16589937
1,,22.0,Tumour marker increased,16589937
0,,22.0,Death,16589974
0,6,22.0,Tumour pseudoprogression,16590226
0,1,22.0,Sepsis,16590283
1,1,22.0,Pancytopenia,16590283
2,1,22.0,Discomfort,16590283
3,1,22.0,Dizziness,16590283
0,1,22.0,Cardiac dysfunction,16590293
0,3,22.0,Nausea,16590320
1,3,22.0,Myalgia,16590320
2,3,22.0,Cancer pain,16590320
0,6,22.0,Pulmonary oedema,16590360
1,6,22.0,Pulmonary haemorrhage,16590360
2,6,22.0,Drug ineffective,16590360
3,6,22.0,Jaundice,16590360
4,6,22.0,Mobility decreased,16590360
5,6,22.0,Mouth haemorrhage,16590360
6,6,22.0,Grip strength decreased,16590360
7,5,22.0,Death,16590360
0,1,22.0,Blood pressure increased,16590390
1,1,22.0,Hepatotoxicity,16590390
2,3,22.0,Hepatic enzyme increased,16590390
3,1,22.0,Neurotoxicity,16590390
4,3,22.0,Malignant neoplasm progression,16590390
0,2,22.0,Brain oedema,16590412
0,6,22.1,Myalgia,16590443
1,6,22.1,Fatigue,16590443
2,6,22.1,Insomnia,16590443
3,6,22.1,Arthralgia,16590443
4,6,22.1,Pain in extremity,16590443
5,6,22.1,Muscle twitching,16590443
0,,22.0,Disease progression,16590540
0,,22.0,Disease progression,16590561
0,,22.0,Erythema,16590569
1,,22.0,Diarrhoea,16590569
0,6,22.1,Hospitalisation,16590737
1,6,22.1,Pruritus,16590737
2,6,22.1,Nausea,16590737
3,6,22.1,Taste disorder,16590737
4,6,22.1,Diarrhoea,16590737
5,6,22.1,Constipation,16590737
6,6,22.1,Dry mouth,16590737
7,6,22.1,Carbohydrate antigen 125 increased,16590737
8,6,22.1,Loss of personal independence in daily activities,16590737
9,6,22.1,Platelet count decreased,16590737
10,6,22.1,Somnolence,16590737
11,6,22.1,Dysphonia,16590737
12,6,22.1,Weight decreased,16590737
13,6,22.1,Vomiting,16590737
14,6,22.1,Fatigue,16590737
15,6,22.1,Underdose,16590737
0,6,22.0,Neutrophil count decreased,16590751
1,6,22.0,Bone marrow failure,16590751
0,1,22.1,Thrombosis,16590774
1,1,22.1,Sepsis,16590774
2,6,22.1,Drug-device incompatibility,16590774
0,1,22.0,Hypercreatininaemia,16590796
1,1,22.0,Azotaemia,16590796
0,3,22.0,Oedema,16590805
1,3,22.0,Weight increased,16590805
2,3,22.0,Renal disorder,16590805
3,3,22.0,Blood creatinine increased,16590805
0,5,22.0,Death,16590830
0,5,22.0,Death,16590831
0,5,22.0,Blood disorder,16590840
0,1,22.0,Fatigue,16590842
1,1,22.0,Diarrhoea,16590842
2,1,22.0,Alopecia,16590842
3,1,22.0,Skin toxicity,16590842
4,1,22.0,Weight decreased,16590842
0,3,22.1,Asthenia,16590845
1,3,22.1,Feeling of despair,16590845
2,6,22.1,Dizziness,16590845
3,3,22.1,Hypertension,16590845
4,3,22.1,Choking,16590845
5,3,22.1,Fatigue,16590845
6,3,22.1,Decreased appetite,16590845
7,6,22.1,Feeling abnormal,16590845
8,6,22.1,Malaise,16590845
9,3,22.1,General physical health deterioration,16590845
0,1,22.0,Thrombocytopenia,16590882
1,6,22.0,Portal hypertension,16590882
2,1,22.0,Arteriosclerosis,16590882
3,6,22.0,Venoocclusive liver disease,16590882
4,2,22.0,Splenomegaly,16590882
5,2,22.0,Varices oesophageal,16590882
0,5,22.0,Lung disorder,16590903
0,1,22.0,Neutrophil count decreased,16590925
1,2,22.0,Arthritis,16590925
0,1,22.0,Erythema,16590928
1,1,22.0,Dyspnoea,16590928
0,6,22.0,Tubulointerstitial nephritis,16590934
0,6,22.0,Pain in extremity,16590937
1,6,22.0,Muscle spasms,16590937
0,3,22.1,Hyperbilirubinaemia,16590951
1,3,22.1,Anaemia,16590951
0,3,22.1,Hypoacusis,16591001
0,3,22.1,Tinnitus,16591013
1,6,22.1,Rash,16591013
2,1,22.1,Drug interaction,16591013
3,3,22.1,Platelet count decreased,16591013
4,1,22.1,Neutropenia,16591013
5,6,22.1,Urinary tract infection,16591013
6,6,22.1,White blood cell count decreased,16591013
7,6,22.1,Red blood cell count decreased,16591013
0,6,22.0,White blood cell count decreased,16591030
0,6,22.0,Pulmonary oedema,16591339
0,5,22.0,Death,16591397
0,6,22.1,Oesophageal adenocarcinoma,16591399
1,6,22.1,Second primary malignancy,16591399
2,3,22.1,Neoplasm progression,16591399
0,6,22.0,Pleural effusion,16591402
1,6,22.0,Positron emission tomogram abnormal,16591402
2,6,22.0,Atelectasis,16591402
3,6,22.0,Pneumothorax,16591402
0,3,22.0,Hair texture abnormal,16591420
1,3,22.0,Alopecia,16591420
2,3,22.0,Madarosis,16591420
3,3,22.0,Hair colour changes,16591420
4,3,22.0,Hair disorder,16591420
0,6,22.1,Hypoacusis,16591422
1,3,22.1,Fatigue,16591422
2,6,22.1,Balance disorder,16591422
3,6,22.1,Gait disturbance,16591422
0,6,22.1,Fatigue,16591454
1,6,22.1,White blood cell count decreased,16591454
2,1,22.1,Sepsis,16591454
3,6,22.1,Blood count abnormal,16591454
0,6,22.1,Fatigue,16591458
1,6,22.1,Asthenia,16591458
2,2,22.1,White blood cell count decreased,16591458
3,6,22.1,Hot flush,16591458
4,6,22.1,Headache,16591458
0,6,22.1,Haemophagocytic lymphohistiocytosis,16591563
1,6,22.1,Platelet count decreased,16591563
0,5,22.0,Death,16591586
0,1,22.0,Blood pressure increased,16591604
0,1,22.0,Purpura,16591639
1,1,22.0,Toxic skin eruption,16591639
0,6,22.0,Urethral stenosis,16591646
0,3,22.0,Diabetes mellitus,16591651
1,2,22.0,Vision blurred,16591651
2,6,22.0,Treatment noncompliance,16591651
0,6,22.0,Metastases to central nervous system,16591678
1,3,22.0,Altered state of consciousness,16591678
2,6,22.0,Prostate cancer,16591678
3,1,22.0,Rash,16591678
0,2,22.0,Hypotension,16591708
1,5,22.0,Pulmonary arterial hypertension,16591708
2,5,22.0,Disease progression,16591708
3,2,22.0,Oedema,16591708
0,3,22.1,Pericardial effusion malignant,16591713
1,2,22.1,Haemoglobin decreased,16591713
2,6,22.1,Neutrophil percentage decreased,16591713
3,6,22.1,Pleural effusion,16591713
0,1,22.0,Gamma-glutamyltransferase increased,16591714
0,6,22.0,Product dose omission,16591838
0,6,22.0,Anaemia,16591857
1,6,22.0,Neutropenia,16591857
2,6,22.0,Thrombocytopenia,16591857
3,6,22.0,Neurotoxicity,16591857
4,6,22.0,Asthenia,16591857
5,6,22.0,Hypertension,16591857
6,6,22.0,Fatigue,16591857
0,1,22.0,Sense of oppression,16591886
1,1,22.0,Flushing,16591886
2,6,22.0,Product use in unapproved indication,16591886
3,1,22.0,Infusion related reaction,16591886
4,6,22.0,Off label use,16591886
0,6,22.0,Feeling abnormal,16591897
1,6,22.0,Product dose omission,16591897
0,6,22.0,Bone marrow failure,16591946
0,1,22.0,Product dose omission,16592003
1,1,22.0,Malaise,16592003
0,1,22.0,Renal failure,16592035
1,1,22.0,Diarrhoea,16592035
2,1,22.0,Hypovolaemic shock,16592035
0,6,22.0,Tumour haemorrhage,16592135
1,6,22.0,Neoplasm progression,16592135
2,5,22.0,Multiple organ dysfunction syndrome,16592135
0,6,22.0,Dyspnoea,16592136
1,6,22.0,Gastric disorder,16592136
0,6,22.1,Mental impairment,16592144
1,3,22.1,Photosensitivity reaction,16592144
2,6,22.1,Varicose vein,16592144
3,3,22.1,Cough,16592144
4,3,22.1,Alopecia,16592144
5,2,22.1,Abdominal distension,16592144
6,2,22.1,Weight decreased,16592144
7,6,22.1,Peripheral swelling,16592144
8,1,22.1,Asthenia,16592144
9,1,22.1,Nausea,16592144
10,1,22.1,Fall,16592144
11,6,22.1,Rash vesicular,16592144
12,6,22.1,Erythema,16592144
13,3,22.1,Insomnia,16592144
14,3,22.1,Mental disorder,16592144
15,3,22.1,Feeling abnormal,16592144
16,3,22.1,Pain in extremity,16592144
17,2,22.1,Acrochordon,16592144
18,6,22.1,Osteoporosis,16592144
19,3,22.1,Abdominal pain,16592144
20,6,22.1,Productive cough,16592144
21,3,22.1,Neuropathy peripheral,16592144
22,2,22.1,Balance disorder,16592144
23,3,22.1,Stress,16592144
24,2,22.1,Depression,16592144
25,2,22.1,Decreased appetite,16592144
26,6,22.1,Blister,16592144
27,6,22.1,Fine motor skill dysfunction,16592144
28,1,22.1,Arthralgia,16592144
29,3,22.1,Fatigue,16592144
30,1,22.1,Blood pressure increased,16592144
31,6,22.1,Crying,16592144
32,6,22.1,Pruritus,16592144
33,3,22.1,Constipation,16592144
0,2,22.0,Hepatitis,16592149
1,1,22.0,Hepatitis B reactivation,16592149
0,1,22.0,Hypotension,16592198
1,1,22.0,Nausea,16592198
2,1,22.0,Rash,16592198
3,1,22.0,Throat tightness,16592198
0,6,22.0,Intentional product use issue,16592203
1,5,22.0,Death,16592203
2,6,22.0,Malignant neoplasm progression,16592203
0,3,22.0,Asthenia,16592206
1,3,22.0,Pelvic pain,16592206
2,3,22.0,Vomiting,16592206
3,3,22.0,Diarrhoea,16592206
0,6,22.0,Pemphigoid,16592211
0,6,22.0,Adverse drug reaction,16592219
0,6,22.1,Cardiac disorder,16592240
1,6,22.1,Back pain,16592240
2,6,22.1,Tympanic membrane perforation,16592240
3,6,22.1,Peripheral swelling,16592240
4,6,22.1,Back pain,16592240
5,6,22.1,Hypoacusis,16592240
6,6,22.1,Dizziness,16592240
0,1,22.0,Ischaemic stroke,16592251
0,6,22.0,Non-small cell lung cancer,16592263
0,6,22.0,Neutropenia,16592286
1,6,22.0,Off label use,16592286
2,6,22.0,Toxicity to various agents,16592286
0,6,22.0,Disease progression,16592303
1,5,22.0,Death,16592303
2,6,22.0,Diarrhoea,16592303
3,3,22.0,Fatigue,16592303
0,1,22.0,Radiation pneumonitis,16592330
1,6,22.0,Malignant neoplasm progression,16592330
0,6,22.0,Malaise,16592360
1,1,22.0,Chills,16592360
2,1,22.0,Pyrexia,16592360
3,6,22.0,Fatigue,16592360
4,1,22.0,Myalgia,16592360
5,1,22.0,Nausea,16592360
6,1,22.0,Abdominal pain upper,16592360
0,3,22.0,Pain in extremity,16592367
1,3,22.0,Arthralgia,16592367
2,3,22.0,Alopecia,16592367
3,3,22.0,Uveitis,16592367
4,3,22.0,Gait disturbance,16592367
5,6,22.0,Drug ineffective,16592367
0,2,22.0,Decreased appetite,16592498
1,6,22.0,Inappropriate schedule of product administration,16592498
2,3,22.0,Hepatic enzyme increased,16592498
3,3,22.0,Alanine aminotransferase increased,16592498
4,3,22.0,Aspartate aminotransferase increased,16592498
5,2,22.0,Decubitus ulcer,16592498
0,2,22.0,Hepatic enzyme increased,16592583
1,2,22.0,Pruritus,16592583
2,2,22.0,Hypertriglyceridaemia,16592583
3,3,22.0,Hypothyroidism,16592583
0,1,22.1,Postpolypectomy syndrome,16592651
1,2,22.1,Anaemia,16592651
2,1,22.1,Colon cancer,16592651
0,3,22.1,Haemorrhagic stroke,16592815
0,5,22.0,Neutropenia,16592833
1,5,22.0,Febrile neutropenia,16592833
0,6,22.0,Abnormal faeces,16592839
1,6,22.0,Product dose omission,16592839
2,2,22.0,Onychoclasis,16592839
3,6,22.0,Influenza,16592839
4,1,22.0,Fatigue,16592839
5,1,22.0,Bone marrow failure,16592839
6,6,22.0,Abdominal pain,16592839
0,5,22.0,Infection,16592843
0,1,22.0,Respiratory failure,16592858
1,6,22.0,Interstitial lung disease,16592858
0,2,22.0,Hepatocellular injury,16592950
1,2,22.0,Cholestasis,16592950
0,1,22.0,Fistula of small intestine,16592968
1,6,22.0,Anaemia,16592968
2,1,22.0,Haematochezia,16592968
3,6,22.0,Fatigue,16592968
4,1,22.0,Gastric disorder,16592968
5,1,22.0,Gastrointestinal ulcer,16592968
0,2,22.1,Cerebral haematoma,16593022
1,1,22.1,Hypertension,16593022
2,2,22.1,Subarachnoid haemorrhage,16593022
0,6,22.0,Generalised oedema,16593062
1,6,22.0,Malignant neoplasm progression,16593062
2,6,22.0,Respiratory failure,16593062
0,1,22.0,Hepatocellular injury,16593082
0,6,22.0,Incorrect dose administered,16593108
1,6,22.0,Inability to afford medication,16593108
2,3,22.0,Dizziness,16593108
3,6,22.0,Therapeutic product effect incomplete,16593108
0,6,22.1,Sinus headache,16593141
1,6,22.1,Sinus disorder,16593141
2,6,22.1,Inability to afford medication,16593141
3,3,22.1,Post procedural diarrhoea,16593141
4,6,22.1,Sinusitis,16593141
5,3,22.1,Hot flush,16593141
6,6,22.1,Intentional product use issue,16593141
7,6,22.1,Memory impairment,16593141
8,3,22.1,Arthralgia,16593141
9,3,22.1,Flatulence,16593141
10,3,22.1,Diarrhoea,16593141
11,6,22.1,Headache,16593141
12,6,22.1,Hypersensitivity,16593141
13,3,22.1,Rheumatoid arthritis,16593141
0,6,22.1,Bradycardia,16593278
0,5,22.0,Cerebral haemorrhage,16593319
0,6,22.0,Spinal disorder,16593325
0,6,22.0,Extrapyramidal disorder,16593343
0,6,22.0,Cerebral infarction,16593344
0,6,22.1,Malignant neoplasm progression,16593345
1,6,22.1,Lung abscess,16593345
2,6,22.1,Hypertension,16593345
3,6,22.1,Pneumonitis,16593345
0,5,22.0,General physical health deterioration,16593352
0,3,22.0,End stage renal disease,16593354
1,3,22.0,Chronic kidney disease,16593354
2,3,22.0,Acute kidney injury,16593354
